<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>146(13)</volume><submitter>Khine HT</submitter><pubmed_abstract>&lt;h4>Abstract&lt;/h4>Epstein-Barr virus (EBV) infects >90% of humans and is associated with both hematological and epithelial malignancies. Here, we analyzed 990 EBV genomes (319 newly sequenced and 671 from public databases) from patients with various diseases to comprehensively characterize genomic variations, including single nucleotide variations (SNVs) and structural variations (SVs). Although most SNVs were a result of conservative evolution and reflected the geographical origins of the viral genomes, we identified several convergent SNV hot spots within the central homology domain of EBNA3B, the transactivation domain of EBNA2, and the second transmembrane domain of LMP1. These convergent SNVs seem to fine-tune viral protein functionality and immunogenicity. SVs, particularly large dele</pubmed_abstract><journal>Blood</journal><pagination>1533-1545</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12824656</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Association of Epstein-Barr virus genomic alterations with human pathologies.</pubmed_title><pmcid>PMC12824656</pmcid><pubmed_authors>Khine HT</pubmed_authors><pubmed_authors>Hamada M</pubmed_authors><pubmed_authors>Son S</pubmed_authors><pubmed_authors>Akutsu Y</pubmed_authors><pubmed_authors>Sawada A</pubmed_authors><pubmed_authors>Watanabe T</pubmed_authors><pubmed_authors>Iizuka A</pubmed_authors><pubmed_authors>Ito Y</pubmed_authors><pubmed_authors>Umeda M</pubmed_authors><pubmed_authors>Kato S</pubmed_authors><pubmed_authors>Sato Y</pubmed_authors><pubmed_authors>Ohshima K</pubmed_authors><pubmed_authors>Naruse A</pubmed_authors><pubmed_authors>Satou A</pubmed_authors><pubmed_authors>Kataoka H</pubmed_authors><pubmed_authors>Murata T</pubmed_authors><pubmed_authors>Kimura H</pubmed_authors><pubmed_authors>Nakaguro M</pubmed_authors><pubmed_authors>Goto K</pubmed_authors><pubmed_authors>Okuno Y</pubmed_authors><pubmed_authors>Kawada JI</pubmed_authors><pubmed_authors>Kojima Y</pubmed_authors><pubmed_authors>Arai H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Association of Epstein-Barr virus genomic alterations with human pathologies.</name><description>&lt;h4>Abstract&lt;/h4>Epstein-Barr virus (EBV) infects >90% of humans and is associated with both hematological and epithelial malignancies. Here, we analyzed 990 EBV genomes (319 newly sequenced and 671 from public databases) from patients with various diseases to comprehensively characterize genomic variations, including single nucleotide variations (SNVs) and structural variations (SVs). Although most SNVs were a result of conservative evolution and reflected the geographical origins of the viral genomes, we identified several convergent SNV hot spots within the central homology domain of EBNA3B, the transactivation domain of EBNA2, and the second transmembrane domain of LMP1. These convergent SNVs seem to fine-tune viral protein functionality and immunogenicity. SVs, particularly large dele</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-07-15T06:31:47.881Z</modification><creation>2026-06-30T03:20:38.139Z</creation></dates><accession>S-EPMC12824656</accession><cross_references><pubmed>40569273</pubmed><doi>10.1182/blood.2024028055</doi></cross_references></HashMap>